Haddadin Zaid, Lee Vivian, Conlin Christopher, Zhang Lei, Carlston Kristi, Morrell Glen, Kim Daniel, Hoffman John M, Morton Kathryn
University of Utah School of Medicine, Salt Lake City, Utah.
Department of Radiology and Imaging Sciences, University of Utah, Salt Lake City, Utah; and.
J Nucl Med Technol. 2017 Mar;45(1):42-49. doi: 10.2967/jnmt.116.180851. Epub 2017 Feb 2.
Glomerular filtration rate (GFR) measurements are critical in patients with hepatic cirrhosis but potentially erroneous when based on serum creatinine. New equations for estimated GFR (eGFR) have shown variable performance in cirrhotics, possibly because of inaccuracies in reference methods for measured GFR (mGFR). The primary objective was to compare the performance of 4 improved eGFR equations with a 1-compartment, 2-sample plasma slope intercept Tc-DTPA mGFR method to determine whether any of the eGFR calculations could replace plasma Tc-DTPA mGFR in patients with cirrhosis. The secondary objective was to test the hypothesis that mGFR using voluntary voided urine collections introduces error compared with plasma-only methods. Fifty-four patients with hepatic cirrhosis underwent mGFR determinations from 2 plasma samples at 1 and 3 h after intravenous administration of 185 MBq of Tc-DTPA. GFR was also generated by a UV/P calculation derived from blood and urine samples. These mGFRs were compared with the eGFRs generated by 4 estimating equations: MDRD (Modified Diet in Renal Disease), CKD-EPI (Chronic Kidney Disease-Epidemiology Collaboration) (serum creatinine [SCr]), CKD-EPI (cystatin [CysC]), and CKD-EPI (CysC+SCr). eGFRs were compared with mGFRs by Pearson correlation, precision, bias, percentage bias, and accuracy (eGFRs varying by <10% [p10], <20% [p20] or <30% [p30] from the corresponding mGFR). All eGFRs showed poorer performance when the UV/P Tc-DTPA mGFR was used as the reference than when the plasma Tc-DTPA mGFR was used. When compared with the plasma Tc-DTPA mGFR method, the performance of all eGFR equations was superior to most published reports. There was a moderately good positive correlation between eGFRs and mGFRs. When compared with plasma Tc-DTPA mGFR, precision of eGFRs was in the range of 14-20 mL/min and showed a negligible bias. Compared with the plasma Tc-DTPA mGFR, CKD-EPI (CysC+SCr) showed the best overall performance and accuracy, at 85.19% (p30), 75.93% (p20), and 42.59% (p10). Estimating equations for measuring eGFR performed better than in most published reports, attributable to use of the plasma Tc-DTPA mGFR method as a reference. CKD-EPI (CysC+SCr) eGFR showed the best overall performance. However, more discriminating methods may be required when accurate GFR measurements are necessary. mGFR measurements using urine collections may introduce error compared with plasma-only methods.
肾小球滤过率(GFR)测定对于肝硬化患者至关重要,但基于血清肌酐进行测定时可能出现误差。新的估算GFR(eGFR)方程在肝硬化患者中表现各异,这可能是由于测定GFR(mGFR)的参考方法存在不准确之处。主要目的是比较4种改进的eGFR方程与单室、双样本血浆斜率截距Tc-DTPA mGFR方法的性能,以确定在肝硬化患者中是否有任何eGFR计算方法可以替代血浆Tc-DTPA mGFR。次要目的是检验以下假设:与仅使用血浆的方法相比,使用随意排尿收集尿液进行mGFR测定会引入误差。54例肝硬化患者在静脉注射185 MBq的Tc-DTPA后1小时和3小时,通过采集两份血浆样本进行mGFR测定。GFR也通过血液和尿液样本的UV/P计算得出。将这些mGFR与4种估算方程得出的eGFR进行比较:MDRD(肾脏病饮食改良法)、CKD-EPI(慢性肾脏病流行病学协作组)(血清肌酐[SCr])、CKD-EPI(胱抑素[CysC])和CKD-EPI(CysC + SCr)。通过Pearson相关性、精密度、偏差、百分比偏差和准确性(eGFR与相应的mGFR相差<10%[p10]、<20%[p20]或<30%[p30])将eGFR与mGFR进行比较。当以UV/P Tc-DTPA mGFR作为参考时,所有eGFR的表现均不如以血浆Tc-DTPA mGFR作为参考时。与血浆Tc-DTPA mGFR方法相比,所有eGFR方程的性能均优于大多数已发表的报告。eGFR与mGFR之间存在中等程度的良好正相关。与血浆Tc-DTPA mGFR相比,eGFR的精密度在14 - 20 mL/min范围内,偏差可忽略不计。与血浆Tc-DTPA mGFR相比,CKD-EPI(CysC + SCr)总体表现和准确性最佳,分别为85.19%(p30)、75.93%(p20)和42.59%(p10)。用于测量eGFR的估算方程比大多数已发表报告中的表现更好,这归因于将血浆Tc-DTPA mGFR方法用作参考。CKD-EPI(CysC + SCr)eGFR总体表现最佳。然而,在需要准确测量GFR时,可能需要更具区分性的方法。与仅使用血浆的方法相比,使用尿液收集进行mGFR测定可能会引入误差。